O
Oriola Oyj
OMXH:OKDBV
Oriola Oyj
OMXH:OKDBV
Price:
1.056
EUR
-3.83%
Market Closed
Market Cap:
€191.7m
Relative Value
The Relative Value of one OKDBV stock under the Base Case scenario is 2.799 EUR. Compared to the current market price of 1.056 EUR, Oriola Oyj is Undervalued by 62%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
OKDBV
Relative Value
Base Case
2.799
EUR
Undervaluation 62%
O
Multiples Across Competitors
OKDBV Competitors Multiples
Oriola Oyj Competitors
Oriola Oyj Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| FI |
O
|
Oriola Oyj
OMXH:OKDBV
|
195.6m EUR | 0.1 | -7.2 | 6.9 | 39.1 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
103.3B USD | 0.3 | 25.5 | 18 | 20.2 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
70.3B USD | 0.2 | 45.3 | 15.3 | 19.6 | |
| US |
|
Cencora Inc
NYSE:COR
|
64.5B USD | 0.2 | 41.5 | 14.1 | 18.1 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
50B USD | 0.2 | 31.2 | 15.3 | 20.1 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
36.3B AUD | 6 | 68.5 | 51.5 | 51.5 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.8B CNY | 0.2 | 11.3 | 15.2 | 15.2 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
63.4B CNY | 1.5 | 17.1 | 13.2 | 13.2 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.9B USD | 0.7 | 22.8 | 11 | 15.4 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
65.7B HKD | 0.1 | 8.6 | 1.6 | 2 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
